The manufacturer of popular weight-loss drugs Ozempic and Wegovy, Novo Nordisk, is taking heat from the federal government for regularly failing to report potential side effects of its GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results